Cargando…
Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype
Uterine serous cancer (USC) is an aggressive subtype of endometrial cancer, with poor survival and high recurrence rates. The development of novel and effective therapies specific to USC would aid in its management. However, few studies have focused solely on this rare subtype. The current study dem...
Autores principales: | Hu, Wen, Zhang, Li, Ferri-Borgogno, Sammy, Kwan, Suet-Ying, Lewis, Kelsey E., Cun, Han T., Yeung, Tsz-Lun, Soliman, Pamela T., Tarapore, Rohinton S., Allen, Joshua E., Guan, Xinyuan, Lu, Karen H., Mok, Samuel C., Au-Yeung, Chi-Lam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563948/ https://www.ncbi.nlm.nih.gov/pubmed/32867127 http://dx.doi.org/10.3390/cancers12092436 |
Ejemplares similares
-
Correction: Hu, W., et al. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. Cancers 2020, 12, 2436
por: Hu, Wen, et al.
Publicado: (2021) -
Ryanodine receptor 1-mediated Ca(2+) signaling and mitochondrial reprogramming modulate uterine serous cancer malignant phenotypes
por: Zhang, Li, et al.
Publicado: (2022) -
Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Promotes Uterine Serous Cancer Cell Proliferation and Cell Cycle Progression
por: Kwan, Suet-Ying, et al.
Publicado: (2020) -
Pathogenesis and Clinical Management of Uterine Serous Carcinoma
por: Zhang, Li, et al.
Publicado: (2020) -
ONC201 and imipridones: Anti-cancer compounds with clinical efficacy
por: Prabhu, Varun Vijay, et al.
Publicado: (2020)